{
    "organizations": [],
    "uuid": "2df02b3be5c8212ee20f2bef435d7e029dda328b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pfizer-begins-phase-1-2-study-to-e/brief-pfizer-begins-phase-1-2-study-to-evaluate-respiratory-syncytial-virus-vaccine-idUSFWN1ST0DF",
    "ord_in_thread": 0,
    "title": "BRIEF-Pfizer Begins Phase 1/2 Study To Evaluate Respiratory Syncytial Virus Vaccine",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - Pfizer Inc:\n* PFIZER BEGINS A PHASE 1/2 STUDY TO EVALUATE RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-22T20:34:00.000+03:00",
    "crawled": "2018-05-23T15:16:40.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "pfizer",
        "inc",
        "pfizer",
        "begin",
        "phase",
        "study",
        "evaluate",
        "respiratory",
        "syncytial",
        "virus",
        "rsv",
        "vaccine",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}